Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03347045 | Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care(TPC-RCT) | unknown | N/A | 50 | Jason MartynOTHER | 0 | Nov 20, 2017 | clinicaltrials |
| NCT00666562 | Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2017 | clinicaltrials |
| NCT02944357 |
| Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery |
| withdrawn |
| N/A |
| 0 |
| Mayo ClinicOTHER |
| 1 |
| Nov 17, 2017 |
| clinicaltrials |
| NCT02993497 | Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia | completed | N/A | 20 | Yonsei UniversityOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00598806 | Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) | completed | Phase 3 | 812 | Spectrum Pharmaceuticals, IncINDUSTRY | 3 | Nov 13, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT03331705 | Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures | unknown | — | 30 | UroSee CorporationINDUSTRY | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02886026 | Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors(LaserIII) | unknown | N/A | 248 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Nov 1, 2017 | clinicaltrials |
| NCT01938573 | Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | completed | Phase 1 / Phase 2 | 21 | University of WashingtonOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT02760953 | TURBt With Adjuvant Cryoablation to Treat Bladder Cancer | unknown | N/A | 150 | Huashan HospitalOTHER | 0 | Oct 19, 2017 | clinicaltrials |
| NCT03150836 | Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer | withdrawn | Phase 2 | 0 | Terence Friedlander, MDOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT02228330 | Prospective Clinical Trial - Obturator Reflex Predictors and Blockage | unknown | N/A | 50 | Rabin Medical CenterOTHER | 1 | Oct 17, 2017 | clinicaltrials |
| NCT02106416 | Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development | completed | N/A | 21 | NYU Langone HealthOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT01955408 | Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment(OABSYNERGO) | completed | — | 35 | Meir Medical CenterOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT03007771 | Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT02655081 | Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy(IMPACT) | completed | Phase 2 | 48 | University of PittsburghOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT00003452 | Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT03296306 | Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma(FOCUS) | unknown | Phase 3 | 330 | Asan Medical CenterOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT03274284 | Chemoradiotherapy for Recurrent T1G3 Bladder Cancer | unknown | Phase 4 | 20 | Assiut UniversityOTHER | 0 | Sep 11, 2017 | clinicaltrials |
| NCT00318266 | NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. | completed | — | 73 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02001857 | Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. | completed | Phase 4 | 200 | University Hospital, GhentOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01200992 | Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer(EMBARC-RF) | terminated | Phase 3 | 84 | Bioniche Life Sciences Inc.INDUSTRY | 6 | Aug 24, 2017 | clinicaltrials |
| NCT01622660 | Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy | terminated | Phase 2 | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02852564 | Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | completed | Phase 1 | 12 | Eugene Lee, MDOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02287701 | Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization | completed | N/A | 24 | NYU Langone HealthOTHER | 1 | Aug 14, 2017 | clinicaltrials |
| NCT01915121 | An Educational Intervention for Patients With Bladder Cancer | completed | N/A | 43 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Aug 4, 2017 | clinicaltrials |
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02039310 | Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy | completed | — | 59 | University of MichiganOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01687244 | Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer | completed | Phase 2 | 40 | FKD Therapies OyINDUSTRY | 0 | Jul 24, 2017 | clinicaltrials |
| NCT02027649 | Detection of K14 in Bladder Cancer With a Non Invasive Technique | terminated | — | 400 | Corporacion Parc TauliOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT00380029 | Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 27 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT03221829 | A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients | unknown | — | 2,800 | Medical University of WarsawOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT02696733 | Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach | unknown | Phase 4 | 100 | Medical University of WarsawOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT01015963 | Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 | completed | — | 69 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2017 | clinicaltrials |
| NCT00330499 | Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer. | completed | Phase 3 | 67 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jul 12, 2017 | clinicaltrials |
| NCT01236053 | Cancer in Patients With Gabapentin (GPRD) | completed | — | 2,323,608 | GlaxoSmithKlineINDUSTRY | 0 | Jul 6, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01042795 | Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy | terminated | Phase 2 | 7 | University of MichiganOTHER | 1 | Jun 28, 2017 | clinicaltrials |
| NCT02925533 | Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract | terminated | Phase 1 | 1 | Mark Pomerantz, MDOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT01108003 | Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery | terminated | N/A | 7 | Roswell Park Cancer InstituteOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT03193788 | Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy(PREMIER) | unknown | Phase 3 | 74 | Asan Medical CenterOTHER | 1 | Jun 21, 2017 | clinicaltrials |
| NCT01803295 | Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC(OPTIMA) | completed | N/A | 80 | UroGen Pharma Ltd.INDUSTRY | 4 | Jun 16, 2017 | clinicaltrials |
| NCT02307487 | Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients | completed | Phase 2 | 14 | UroGen Pharma Ltd.INDUSTRY | 1 | Jun 16, 2017 | clinicaltrials |
| NCT02778243 | Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level(STERPROSER) | completed | N/A | 107 | Hopital FochOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01108055 | Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer | completed | Phase 2 | 43 | Sandy SrinivasOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT00005047 | 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer | terminated | Phase 3 | 521 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 8, 2017 | clinicaltrials |
| NCT03174912 | In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? | completed | Phase 4 | 400 | Ankara Training and Research HospitalOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT02738827 | Diode Laser Treatment of Bladder Tumors | completed | N/A | 21 | Gregers Gautier HermannOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 20, 2017source: clinicaltrials